By Tarek Rabah, AstraZeneca’s Area Vice President for Middle East and Africa
As bilateral donors and development banks put increasing pressure on governments in low and middle income countries (LMICs) to cover a greater proportion of their national health budgets, developing sustainable solutions for public health challenges has never been more important. The private sector has a key role to play in the effort to make sustainable impact. While governments in these countries will increasingly take responsibility for their health care costs over time, private sector investments in health systems that offer a financial return will support ministries of health to achieve their goals more quickly and sustainably. In recognition of this, AstraZeneca has made an organization-wide commitment to make available its knowledge, skills and products to address Africa’s growing non-communicable disease burden.
Nearly a third of African adults were estimated to have high blood pressure in 2014, the highest prevalence of any region.1 HEALTHY HEART AFRICA, our first large-scale initiative in this effort, seeks to tackle the burden of hypertension across the continent by investing in the health systems required to address this highly treatable condition, while ensuring patients can access affordable low cost of supplied anti-hypertensive medicines. This innovative and sustainable approach aims to reach 10 million hypertensive patients across the continent by 2025, supporting the WHO’s target of reducing the global prevalence of hypertension by 25 percent by the same year.
Launched in October 2014 in Kenya, Healthy Heart Africa is partnering with the Ministry of Health and seven on-the-ground organizations – Abt Associates, AMPATH, AMREF Kenya, CHAK, Jhpiego, MEDS and PSI’s network partner PS Kenya, – to work against three main pillars:
• Education & Awareness: Conducting prevention and disease awareness raising activities that will encourage people to live healthier lifestyles and seek screening and diagnosis when needed.
• Training & Guidelines: Training healthcare workers to provide comprehensive and appropriate hypertension care, based on guidelines developed in collaboration with professional societies and the Kenyan Ministry of Health.
• Access & Affordability: Strengthening the supply chain and ensuring patients can access affordable, high-quality anti-hypertensive medicines.
Successful components of this demonstration phase will be scaled in Kenya and to other countries beginning in 2016. Our hope is that this approach will allow the millions of adults with hypertension on the continent to have greater access to the care and treatment they require, not only today, but in 10 years from now.
Read more about the Healthy Heart Africa campaign online and at pulse.psi.org.